Effects of ginseng supplementation on supramaximal exercise performance and short-term recovery.

The purpose of this study was to examine the effects of long-term ginseng supplementation on short, supramaximal exercise performance and short-term recovery. Using a double-blind protocol, 24 healthy, active women were randomly assigned to a ginseng (n = 12) or placebo (n = 12) treatment group. Each participant added a standardized extract of Panax ginseng C.A. Meyer (400 mg per day of G115) or placebo to their normal diet for 8 weeks (56-60 days). Before and after the trial period, each subject performed an all-out-effort, 30-second leg cycle ergometry test (Wingate protocol) followed by a controlled recovery under constant laboratory conditions. Nineteen subjects completed the study. Analysis of variance using pretest to posttest change scores revealed no significant difference between the ginseng and placebo study groups for the following variables measured: peak anaerobic power output, mean anaerobic power output, rate of fatigue, and immediate postexercise recovery heart rates (p > 0.05). In conclusion, the present data indicate that prolonged supplementation with ginseng (P. ginseng C.A. Meyer) has no ergogenic benefits during and in the recovery from short, supramaximal exercise.

Mucosal IgA response to repeated wingate tests in females.

The purpose of this study was to examine the effect of repeated bouts of brief, intermittent, maximal effort exercise on the concentration of secretory IgA (S-IgA) and incidence of upper respiratory tract infection (URTI) in females. Twenty-six non-smoking, active, adult females participated in this study. The exercise intervention consisted of three consecutive, all-out 30-second Wingate leg cycling tests (0.075 kg/kg body mass), which were separated by three minutes of recovery. Unstimulated saliva was collected prior to (PRE) and five minutes after completion (POST) of the exercise testing protocol. IgA, protein and osmolality were measured, and secretory IgA (SIgA), IgA:Protein, and IgA: Osmolality were calculated. In addition, subjects completed standard logs indicating signs and symptoms of upper respiratory tract infection (URTI) for three weeks following the test. Saliva flow rates (478.5 +/- 50; 345.4 +/- 50 microl/min), S-IgA (55.8 +/- 4.7; 35.4 +/- 3.6 microg/min), and IgA: Protein ratio (30.7 +/- 3.0; 17.5 +/- 1.8 microg IgA/mg protein) were significantly lower POST compared to PRE (P < 0.05). No significant differences were observed for raw IgA, protein, osmolality, and IgA: osmolality. The results of this study show that brief, intermittent, maximal effort exercise results in an acute decrease in S-IgA in healthy adult females in less than eight minutes. However, this exercise induced transient decrease did not appear to be associated with an increase in clinical symptoms of URTI in the weeks following the exercise test intervention.